Literature DB >> 19293618

[Anconeus arthroplasty: a salvage procedure in recurrent heterotopic ossification].

Aksel Seyahi1, Ata Can Atalar, Mehmet Demirhan.   

Abstract

Anconeus interpositional arthroplasty has been used in the treatment of radiocapitellar and radioulnar joint problems occurring after trauma. We performed anconeus interposition arthroplasty in a 31-year-old male patient who developed heterotopic ossification (HTO) in the elbow following surgical treatment of an isolated radial neck fracture. Treatment with implant removal and excision of the radial head resulted in recurrent HTO and a stiff elbow. The patient underwent excision of the heterotrophic new bone and mobilization of the proximal radius. The anconeus muscle was mobilized and interposed between the proximal radius and ulna. Sixteen months after the operation, forearm rotation, elbow flexion and extension increased by 80 degrees , 45 degrees , and 60 degrees , respectively. Control X-rays showed maintenance of the radiohumeral gap without any signs of HTO.

Entities:  

Mesh:

Year:  2009        PMID: 19293618     DOI: 10.3944/AOTT.2009.062

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  3 in total

1.  Heterotopic ossification of the elbow after closed reduction and retrograde intramedullary nailing for radial neck fracture treated by anconeus interposition.

Authors:  T Sreenivas; Jagdish Menon; A R Nataraj
Journal:  Musculoskelet Surg       Date:  2012-01-06

2.  [Treatment of Mason type II radial head fractures by percutaneous reduction].

Authors:  P Simon; F Unterhauser; P von Roth; G Schmidmaier; T Winkler
Journal:  Unfallchirurg       Date:  2014-04       Impact factor: 1.000

3.  Effect of Anconeus Muscle Blocking on Elbow Kinematics: Electromyographic, Inertial Sensors and Finite Element Study.

Authors:  Israel Miguel-Andres; Teresa Alonso-Rasgado; Alan Walmsley; Adam C Watts
Journal:  Ann Biomed Eng       Date:  2016-08-29       Impact factor: 3.934

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.